The goal of this event is to emphasise on an early medicine development and regulatory interactions.
Existing tools such as orphan designation, protocol assistance and PRIME scheme will be highlighted and explained in the context of early product development strategy.
Dr Daria Julkowska from EJP RD will be presenting on current funding schemes.
For registration, please click here